scholarly journals Pulmonary tuberculosis co-infection and COVID-19 in Senegal

2020 ◽  
pp. 1-4
Author(s):  
Agbogbenkou Tevi Déla-dem Lawson ◽  
◽  
Fulgence Abdou Faye ◽  
Adama Berthe ◽  
◽  
...  
Keyword(s):  
Risk Factor ◽  
Severe Acute Respiratory Syndrome ◽  
Pulmonary Tuberculosis ◽  
Potential Risk ◽  
Regional Hospital ◽  
Lung Damage ◽  
Treatment Center ◽  
Adequate Treatment ◽  
The World ◽  
Fragmented Data

New Coronavirus Disease (SARS-CoV-2) is responsible for the severe acute respiratory syndrome. Appeared in Wuhan, China, in December 2019, it affects more than 188 countries around the world to date. Africa is not spared by this pandemic (COVID-19), which is on the rise. Tuberculosis (TB), a disease endemic in Africa with a fatality of 1.5 million people per year , like COVID-19, is transmitted mainly by the respiratory route and affects the lungs[1,2]. In the literature, few studies have demonstrated the association and interactions between these two pathologies. However, the fragmented data reveal that tuberculosis with pulmonary localization must be considered as a potential risk factor for aggravation or complication of the disease. COVID-19, especially since the lung damage is significant, therefore In the fight against the COVID-19 pandemic, we must not forget to suspect and appropriately manage tuberculosis [2]. We report here the case of 3 patients who presented with COVID-19-Tuberculosis co-infection, treated at the level of the Epidemic Treatment Center (CTE) of the Thiès regional hospital in Senegal and whose evolution is favorable under early and adequate treatment.

Opium consumption: A potential risk factor for lung cancer and pulmonary tuberculosis

2016 ◽  
Vol 53 (4) ◽  
pp. 587 ◽  
Author(s):  
SAJ Mousavi ◽  
A Safari ◽  
M Reazai ◽  
A Tangestaninejad ◽  
AR Mafi
Keyword(s):  
Lung Cancer ◽  
Risk Factor ◽  
Pulmonary Tuberculosis ◽  
Potential Risk ◽  
Potential Risk Factor

The demographic determinants of Africa’s changing global position

Human Affairs ◽  
2018 ◽  
Vol 28 (4) ◽  
pp. 367-378
Author(s):  
Valéria Bankóová
Keyword(s):  
Risk Factor ◽  
Potential Risk ◽  
Potential Risk Factor ◽  
World Population ◽  
African Development ◽  
The World ◽  
Economic Position ◽  
New Distribution ◽  
Demographic Growth

Abstract Demographic growth has in recent years been one of the determining characteristics of African development, and if projections are correct, the continent is set to become a population superpower. Its proportion of the world population, especially relative to the “old continent”, is increasing in a historically unprecedented manner, and its inhabitants are younger than ever. Although it is still difficult to assess whether this trend should be regarded as an opportunity or as a potential risk factor, it is already possible to discern the first definitive signs of how this evolving new distribution of demographic power is shifting Africa’s geopolitical and economic position in today’s polycentric world.

scholarly journals Psoriasis and uveitis: a literature review

2012 ◽  
Vol 87 (6) ◽  
pp. 877-883 ◽  
Author(s):  
Naiara Abreu de Azevedo Fraga ◽  
Maria de Fátima Paim de Oliveira ◽  
Ivonise Follador ◽  
Bruno de Oliveira Rocha ◽  
Vitória Regina Rêgo
Keyword(s):  
Metabolic Syndrome ◽  
Risk Factor ◽  
Vision Loss ◽  
Intraocular Inflammation ◽  
Joint Involvement ◽  
World Population ◽  
Adequate Treatment ◽  
Immune Mediated ◽  
The World ◽  
Inflammatory Drugs

Psoriasis is a systemic, chronic, immunologically mediated disease, with significant genetic and environmental influences. It affects from 1 to 3% of the world population. Recently, the relation between psoriasis and different comorbidities, particularly metabolic syndrome, has become extremely relevant. Uveitis is characterized by a process of intraocular inflammation resulting from various causes. Considering psoriasis and uveitis as immune-mediated diseases, this study aims to evaluate the possible association of psoriasis and/or psoriatic arthritis with uveitis and its subtypes. Few studies have evaluated the association of uveitis and psoriasis without joint involvement. It seems that psoriasis without arthropathy is not a risk factor for the development of uveitis. Uveitis tends to develop more frequently in patients with arthropathy or pustular psoriasis than in patients with other forms of psoriasis. Ophthalmic examination should be performed periodically in patients with psoriasis and uveitis. If ophthalmopathy is diagnosed, the patient should receive adequate treatment with anti-inflammatory drugs or immunomodulators to prevent vision loss.

scholarly journals CURRENT ISSUES OF REHABILITATION OF PATIENTS WITH RESPIRATORY DISEASES АТ CLIMATIC RESORT

2020 ◽  
Vol 26 (3) ◽  
pp. 74-77 ◽  
Author(s):  
L. Sh. Dudchenko ◽  
V. V. Ezhov ◽  
V. I. Mizin ◽  
S. N. Belyaeva ◽  
G. G. Maslikova ◽  
...  
Keyword(s):  
Respiratory Diseases ◽  
High Probability ◽  
Rehabilitation Medicine ◽  
Medical Rehabilitation ◽  
Lung Damage ◽  
Adequate Treatment ◽  
Treatment And Prevention ◽  
The World ◽  
Recovery Treatment ◽  
Coronavirus Infection

Respiratory diseases are a serious health problem due to their wide prevalence, not always adequate treatment, sufficiently high probability of developing complications, and frequent formation of disability. One of the important tasks of the development of rehabilitation medicine in the resorts of Russia is to improve programs for the recovery treatment and prevention of respiratory diseases. The spread around the world of a new coronavirus infection, with the most frequent lung damage, has set a new task – the rehabilitation of patients who have suffered pneumonia caused by COVID-19. It is necessary to develop regional standards for sanatorium-resort medical rehabilitation, which made it possible to rationally use the recreational potential of the coastal climatic resorts of Crimea for patients with various respiratory diseases.

Vaccine Targeted Prophylaxis For Covid-19: A Comprehensive Review

2021 ◽  
Vol 12 (3) ◽  
pp. 1850-1860
Author(s):  
Sonia Goswami ◽  
Nagarajan K ◽  
Praveen K. Dixit ◽  
Vidhu Saxena ◽  
Richa Goel ◽  
...  
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
Potential Risk ◽  
Well Being ◽  
World Health ◽  
Comprehensive Review ◽  
Corona Virus ◽  
The World ◽  
The Face ◽  
Health Organization ◽  
Game Changer

The Severe acute respiratory syndrome coronavirus-2, the contamination that prompts sickness19(covid-19), has spread quickly from the initially known cases in china in December 2019 to nations round the globe. On March 10,2020, the world health organization reported that there have been 113,702 affirmed instances of corona virus -19 round the globe, additionaly to 4,012 passing. Due to this worldwide well being emergency analysts are handling build up a corona virus immunization. Protected and compelling immunizations are going to be a game changer: yet for years to return we should always wearing covers, genuinely separating and staying faraway from swarms. Being inoculated doesn't imply that we will laugh in the face of any potential risk and put ourselves as well as other people in danger, especially in light of the very fact that it is as yet not satisfactory what proportions the antibodies can ensure against sickness also as against contamination and transmission. Vaccine for corona virus are basic devices for managing the pandemic when joined with compelling testing and existing anticipation measures. The general undertaking to form a secure and effective coronavirus vaccine is proving to be fruitful. A handful of vaccines now are authorized round the globe, may more in development. Antibodies save an excellent many lives per annum.

Mechanisms of liver damage in COVID-19

2020 ◽  
Vol 1 (19) ◽  
pp. 39-46
Author(s):  
T. V. Pinchuk ◽  
N. V. Orlova ◽  
T. G. Suranova ◽  
T. I. Bonkalo
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Transplantation ◽  
Risk Factor ◽  
Liver Disease ◽  
Liver Function ◽  
Liver Damage ◽  
The World ◽  
Coronavirus Infection ◽  
The Impact ◽  
Analyze Data

At the end of 2019, a new coronavirus (SARS-CoV-2) was discovered in China, causing the coronavirus infection COVID-19. The ongoing COVID-19 pandemic poses a major challenge to health systems around the world. There is still little information on how infection affects liver function and the significance of pre-existing liver disease as a risk factor for infection and severe COVID-19. In addition, some drugs used to treat the new coronavirus infection are hepatotoxic. In this article, we analyze data on the impact of COVID-19 on liver function, as well as on the course and outcome of COVID-19 in patients with liver disease, including hepatocellular carcinoma, or those on immunosuppressive therapy after liver transplantation.

The relevance of dietetic approach of Ayurveda from the perspective of COVID-19 pandemic

2020 ◽  
Vol 11 (SPL1) ◽  
pp. 748-752
Author(s):  
Swapnali Khabade ◽  
Bharat Rathi ◽  
Renu Rathi
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
Healthy Person ◽  
World Health ◽  
Physical And Mental Health ◽  
Leading Role ◽  
Global Pandemic ◽  
The People ◽  
The World ◽  
Health Organization ◽  
The Individual

A novel, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causes severe acute respiratory syndrome and spread globally from Wuhan, China. In March 2020 the World Health Organization declared the SARS-Cov-2 virus as a COVID- 19, a global pandemic. This pandemic happened to be followed by some restrictions, and specially lockdown playing the leading role for the people to get disassociated with their personal and social schedules. And now the food is the most necessary thing to take care of. It seems the new challenge for the individual is self-isolation to maintain themselves on the health basis and fight against the pandemic situation by boosting their immunity. Food organised by proper diet may maintain the physical and mental health of the individual. Ayurveda aims to promote and preserve the health, strength and the longevity of the healthy person and to cure the disease by properly channelling with and without Ahara. In Ayurveda, diet (Ahara) is considered as one of the critical pillars of life, and Langhana plays an important role too. This article will review the relevance of dietetic approach described in Ayurveda with and without food (Asthavidhi visheshaytana & Lanhgan) during COVID-19 like a pandemic.

Plasma therapy a possible hope to fight against COVID-19

2020 ◽  
Author(s):  
Ravikant Piyush ◽  
Aroni Chatterjee ◽  
Shashikant Ray
Keyword(s):  
Middle East ◽  
Severe Acute Respiratory Syndrome ◽  
Viral Disease ◽  
Plasma Therapy ◽  
Therapeutic Drugs ◽  
Wild Fire ◽  
The World ◽  
Short Span ◽  
Game Changer

The world is currently going through a disastrous event and a catastrophic upheaval caused by the coronavirus disease 2019 (COVID-19). The pandemic has resulted in loss of more than 150000 deaths across the globe. Originating from China and spreading across all continents within a short span of time, it has become a matter of international emergency. Different agencies are adopting diverse approaches to stop and spread of this viral disease but still now nothing confirmatory has come up. Due to lack of vaccines and proper therapeutic drugs, the disease is still spreading like wild fire without control. An Old but very promising method- the convalescent plasma therapy could be the key therapy to stop this pandemic. This method has already proven its mettle on several occasions previously and has been found to be effective in curing the pandemics induced by Ebola, severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) belongs to the same group of β-Coronavirus that has resulted in the above diseases. Therefore, the role of plasma therapy is being explored for treatment of this disease. In this review, we have mainly focused on the role of convalescent plasma therapy and why its use should be promoted in fight against COVID-19, as it could turn out to be a game changer.

scholarly journals From the Infection to the Immunotherapy in Cervical Cancer: Can We Stop the Natural Course of the Disease?

Vaccines ◽  
2020 ◽  
Vol 8 (4) ◽  
pp. 597
Author(s):  
Daniela Luvero ◽  
Salvatore Lopez ◽  
Giorgio Bogani ◽  
Francesco Raspagliesi ◽  
Roberto Angioli
Keyword(s):  
Cervical Cancer ◽  
Radiation Therapy ◽  
Risk Factor ◽  
Hpv Vaccine ◽  
Global Market ◽  
Cancer Death ◽  
Prevention Measures ◽  
Primary And Secondary Prevention ◽  
The World ◽  
Prevention And Treatment

Cervical cancer (CC) is the second leading cause of cancer death in women aged 20–39 years. Persistent infection with oncogenic types of human papillomavirus (HPV) represents the most important risk factor for the development of cervical cancer. Three HPVs vaccines are currently on the global market: bivalent, quadrivalent, and nonavalent. The nonavalent vaccine provides protection against almost 90% of HPV-related CC. Despite availability of primary and secondary prevention measures, CC persists as one of the most common cancers among women around the world. Although CC is a largely preventable disease, management of persistent or recurrent CC no longer amenable to control with surgery or radiation therapy has not improved significantly with the progress of modern chemotherapy and disseminated carcinoma of the cervix remains a discouraging clinical entity with a 1-year survival rate between 10% and 15%. Over the last few years, there has been increasing interest in immunotherapy as a strategy to fight tumors. This article focuses on recent discoveries about the HPV vaccine and immunotherapies in the prevention and treatment of CC, highlighting the future view.

scholarly journals Deepening of In Silico Evaluation of SARS-CoV-2 Detection RT-qPCR Assays in the Context of New Variants

Genes ◽  
2021 ◽  
Vol 12 (4) ◽  
pp. 565
Author(s):  
Mathieu Gand ◽  
Kevin Vanneste ◽  
Isabelle Thomas ◽  
Steven Van Gucht ◽  
Arnaud Capron ◽  
...  
Keyword(s):  
Performance Evaluation ◽  
Severe Acute Respiratory Syndrome ◽  
In Silico ◽  
The Other ◽  
Viral Rna ◽  
Potential Threat ◽  
The World

For 1 year now, the world is undergoing a coronavirus disease-2019 (COVID-19) pandemic due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The most widely used method for COVID-19 diagnosis is the detection of viral RNA by RT-qPCR with a specific set of primers and probe. It is important to frequently evaluate the performance of these tests and this can be done first by an in silico approach. Previously, we reported some mismatches between the oligonucleotides of publicly available RT-qPCR assays and SARS-CoV-2 genomes collected from GISAID and NCBI, potentially impacting proper detection of the virus. In the present study, 11 primers and probe sets investigated during the first study were evaluated again with 84,305 new SARS-CoV-2 unique genomes collected between June 2020 and January 2021. The lower inclusivity of the China CDC assay targeting the gene N has continued to decrease with new mismatches detected, whereas the other evaluated assays kept their inclusivity above 99%. Additionally, some mutations specific to new SARS-CoV-2 variants of concern were found to be located in oligonucleotide annealing sites. This might impact the strategy to be considered for future SARS-CoV-2 testing. Given the potential threat of the new variants, it is crucial to assess if they can still be correctly targeted by the primers and probes of the RT-qPCR assays. Our study highlights that considering the evolution of the virus and the emergence of new variants, an in silico (re-)evaluation should be performed on a regular basis. Ideally, this should be done for all the RT-qPCR assays employed for SARS-CoV-2 detection, including also commercial tests, although the primer and probe sequences used in these kits are rarely disclosed, which impedes independent performance evaluation.

Sign in / Sign up

Export Citation Format

Share Document